Explainer: What Is PhRMA?
CSL CEO Paul Perreault recently joined the board of the Pharmaceutical Research and Manufacturers of America.
CSL CEO Paul Perreault on Rare Disease Day
See the video Perreault shared with employees: “Reflect on the work we do and the people who count on us to keep innovating.”
Industry Partnership Fuels Research, Advocacy
PhRMA membership expands CSL Behring’s opportunity for cooperation between industry leaders.
CSL CEO at Utah Life Sciences Summit
At biotech event, Paul Perreault will talk about the company’s COVID-19 response – including a potential treatment now in a c…
Three Quotes About an Unprecedented Year
When CSL Limited announced its end-of-year results, company leaders took stock of where we’ve been and where we’re headed.
Watch Online: CSL CEO at a White House Roundtable
Perreault made the case for a plasma-based hyperimmune to treat COVID-19.
CEO Paul Perreault at White House Roundtable
Perreault, representing the plasma industry, said an antibody treatment depends on additional donations from recovered patien…
CSL CEO: Don't Rush the COVID-19 Vaccine
Joining scientists and medical experts, Perreault urges rigor, precision and the necessary time to ensure vaccine safety.
Dealing With Challenges Head-On
CSL Limited CEO Paul Perreault offers a message of encouragement during the COVID-19 pandemic.
Podcast With CSL CEO Paul Perreault
“I want to make sure that we’re all supporting each other, practicing self-care, and if anybody reaches out, we’re there to t…